UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing

Hydromer, Inc., a leader in advanced coating technologies, announced an exciting expansion into the manufacturing of automated high-speed coating and UV curing equipment as of February 10, 2026. Based in Concord, NC, Hydromer has established a reputation for over 40 years in providing hydrophilic, thromboresistant, and antimicrobial coatings. This strategic move aims to deliver an integrated solution for medical device manufacturers by combining proprietary coatings with state-of-the-art machinery, allowing for a streamlined process that enhances compliance with ISO 13485 and FDA regulations.

The new equipment offerings include a range of innovative systems: hydrophilic coating equipment that ensures uniform application with minimal manual input, an automated high-throughput coating system facilitating higher production rates with reduced dependency on manual labor, and specialized friction testing equipment for accurate lubricity testing. These advancements not only support the performance evaluation and quality control of medical devices but also provide manufacturers with a direct correlation between process parameters and their outcomes.

Michael Torti, CEO of Hydromer, emphasized the company's commitment to enhancing coating performance and manufacturing consistency. By supplying their own equipment, Hydromer aims to eliminate technical barriers for clients, thereby expediting their time to market while upholding stringent quality standards.

Furthermore, Hydromer operates under various compliance standards, including Good Manufacturing Practice and ISO certifications, ensuring a high-quality service for clients across the U.S., Europe, and Asia-Pacific. As a comprehensive B2B solutions provider in surface modification and coating, Hydromer continues to lead through innovation and a dedication to developing proprietary formulations, underscoring its pivotal role in the global medical device sector.

Hydromer, Inc. (OTC: HYDI) recently announced a significant expansion into the manufacturing of automated high-speed coating and UV cure equipment, marking a pivotal development for the company. This strategy serves to enhance its position in the medical device industry by providing an integrated solution that combines proprietary coating technologies with advanced manufacturing equipment.

Investors should take note of several key aspects of this expansion. Firstly, the move solidifies Hydromer's market offering, allowing the company to offer a full suite of services — from coating formulations to the machinery that applies them. This end-to-end solution not only enhances product quality but also provides clients with a streamlined process, reducing their time to market and improving operational efficiency.

Additionally, Hydromer's commitment to compliance with stringent ISO and FDA regulations positions it favorably in a highly regulated industry. As medical devices continue to adopt innovative materials and coatings, Hydromer’s advancements could lead to increased demand for its products and services, strengthening its revenue stream.

Moreover, the focus on automation and high-throughput systems addresses a critical pain point in manufacturing: the reliance on manual labor. By offering equipment that can be operated with minimal human intervention, Hydromer capitalizes on the industry's shift towards automation, reducing overhead costs for its clients and enhancing its competitive edge.

From an investment perspective, while the expansion represents potential growth, it's essential to remain cautious. As with any forward-looking strategy, there are inherent risks and uncertainties. Investors should monitor Hydromer's performance in the coming quarters to assess the realization of its projected benefits and to evaluate any impacts on its financial health.

In conclusion, Hydromer’s expansion is a strategic move that warrants attention from both current and potential investors, given its implications for growth and innovation in a key industry sector.